Employers with insured group health plans may soon receive a medical loss ratio (MLR) rebate from their health insurance issuers. Issuers who did not meet the applicable MLR percentage for 2023 must provide rebates to plan sponsors by Sept. 30, 2024. These rebates may be in the form of a premium credit or a lump sum payment.
HIGHLIGHTS AND ACTION STEPS
Issuers who did not meet their MLR percentage for 2023 must provide rebates by Sept. 30, 2024. As a general rule, an employer who receives a rebate should use it within three months to avoid ERISA’s trust requirement. For rebates received on Sept. 30, 2024, this three-month deadline is Dec. 30, 2024. This deadline should be adjusted for rebates received before Sept. 30, 2024. Employers who receive MLR rebates should also be prepared to answer questions from employees about the rebate and how it is being allocated.
MLR RULES
The MLR rules require health insurance issuers to spend a minimum percentage of their premium dollars on medical care and health care quality improvement. This percentage is 85% for issuers in the large group market and 80% for issuers in the small and individual group markets. States may set higher MLR standards than the federal 80%/85% thresholds. Issuers must report to the federal government how they spent their premium dollars for each calendar year by July 31 of the following year. Issuers who do not meet the applicable MLR standard must provide rebates by Sept. 30, following the end of the MLR reporting year. Issuers who issue rebates must provide plan sponsors and participants with a notice explaining the rebate and how it was calculated.
Related Blogs
Employee Benefits
PUBLISHED
February 20th, 2026
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn Deck
The Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
Benefits+
PUBLISHED
February 10th, 2026
Employer Response to Pharma Shifts
Chris Antypas
Volatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
Benefits+
PUBLISHED
February 9th, 2026
White House Launches TrumpRx, Unveils Drug Prices
DeAnn Deck
On Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
Benefits+
PUBLISHED
February 6th, 2026
DOL Issues Updated Model Employer CHIP Notice
DeAnn Deck
The U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More
Benefits+
PUBLISHED
February 5th, 2026
Prescription Drug Reporting (RxDC Report)
DeAnn Deck
The No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report ...
Read More
Benefits+
PUBLISHED
February 4th, 2026
Major Federal PBM Reforms Enacted as DOL Proposes New PBM Fee-Disclosure Rule
DeAnn Deck
Federal oversight efforts directed at the pharmaceutical benefit manager (PBM) industry have expanded in recent years, culminating in several significant actions. On Feb. 3, ...
Read More